Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Estrella Immunopharma, Inc. - Common Stock (NQ:ESLA)

1.050 +0.090 (+9.38%)
Streaming Delayed Price Updated: 3:59 PM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 62,350
Open 0.9800
Bid (Size) 1.040 (24)
Ask (Size) 1.050 (38)
Prev. Close 0.9600
Today's Range 0.9800 - 1.080
52wk Range 0.6300 - 1.780
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Estrella Immunopharma Announces Activation of Additional Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
From Estrella Immunopharma, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga

Performance

YTD
-6.3%
-6.3%
1 Month
+11.7%
+11.7%
3 Month
+2.9%
+2.9%
6 Month
+9.4%
+9.4%
1 Year
-11.0%
-11.0%

More News

Read More
Estrella Immunopharma Announces Approximately $3.35 Million Private Placement Equity Financing
From Estrella Immunopharma, Inc.
Via Business Wire
Estrella Immunopharma Initiates Second Cohort and Doses First Patient in STARLIGHT-1 Trial of EB103 in Advanced B-Cell Non-Hodgkin’s Lymphomas
From Estrella Immunopharma, Inc.
Via Business Wire
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Buy Rating With a Price Target of $14.00 From CB Capital Partners
From Estrella Immunopharma, Inc.
Via Business Wire
Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week
Via Stocktwits
Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort
From Estrella Immunopharma
Via Business Wire
Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital
From Estrella Immunopharma, Inc.
Via Business Wire
This aTyr Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells
From Estrella Immunopharma, Inc.
Via Business Wire
Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member
From Estrella Immunopharma, Inc.
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
ESLA Stock Earnings: Estrella Immunopharma Reported Results for Q3 2024
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Next Big Thing: 3  Biotech Stocks to Watch for Groundbreaking Advances
Via InvestorPlace
Topics Economy
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Estrella Immunopharma, Inc. - Common Stock publicly traded?
Yes, Estrella Immunopharma, Inc. - Common Stock is publicly traded.
What exchange does Estrella Immunopharma, Inc. - Common Stock trade on?
Estrella Immunopharma, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Estrella Immunopharma, Inc. - Common Stock?
The ticker symbol for Estrella Immunopharma, Inc. - Common Stock is ESLA on the Nasdaq Stock Market
What is the current price of Estrella Immunopharma, Inc. - Common Stock?
The current price of Estrella Immunopharma, Inc. - Common Stock is 1.050
When was Estrella Immunopharma, Inc. - Common Stock last traded?
The last trade of Estrella Immunopharma, Inc. - Common Stock was at 08/29/25 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.